Background
Versata Development Group held U.S. Patent No. 6,553,350, which claimed a method for determining the price of products sold to customers using organizational and product group hierarchies — essentially a computerized system for applying tiered pricing rules across complex enterprise sales hierarchies. SAP America, a major enterprise software company, was accused of infringing the patent through its pricing software products.
The litigation began in district court, where Versata won a $391 million damages verdict in 2011 (the subject of a separate 2013 Federal Circuit appeal). SAP simultaneously filed one of the very first petitions for covered business method (CBM) patent review under the America Invents Act (AIA), which created the CBM program as a streamlined PTAB proceeding for challenging business method patents. The PTAB instituted review and issued a final written decision in 2013 finding that the ‘350 patent’s claims were unpatentable under 35 U.S.C. § 101 as directed to an abstract idea without significantly more. The PTAB also found the claims would have been obvious and lacked written description support.
Versata appealed the PTAB’s final written decision to the Federal Circuit — the first such appeal from a CBM proceeding to reach the court. The case raised threshold jurisdictional questions about whether and to what extent the Federal Circuit could review CBM final written decisions, as well as the substantive § 101 question.
The Court’s Holding
Chief Judge Prost, writing for the Federal Circuit, affirmed the PTAB’s final written decision in full. On jurisdiction, the court held that the Federal Circuit has authority under the AIA to review CBM final written decisions and that such review is not limited to procedural questions — the court can review substantive determinations including § 101 patent eligibility. The court also held that whether a patent qualifies for CBM review (i.e., whether it is a “covered business method patent”) is itself reviewable on appeal, rejecting Versata’s argument that the PTAB’s institution decision on CBM eligibility was unreviewable.
On the merits under § 101, the court applied the Alice framework (the Supreme Court had decided Alice Corp. v. CLS Bank in June 2014) and agreed with the PTAB that Versata’s pricing claims were directed to the abstract idea of determining a price using product/customer group hierarchies. The claimed steps of organizing products and customers into groups and applying pricing rules through those hierarchies represented a longstanding business practice that the computer implementation did not meaningfully transform. The court affirmed the PTAB’s invalidity determination under § 101, which mooted the obviousness and written description grounds.
Key Takeaways
- The Federal Circuit has jurisdiction to review CBM final written decisions on the merits, including substantive § 101 eligibility — these are not purely procedural proceedings insulated from appellate review.
- Whether a patent qualifies as a “covered business method patent” is a reviewable question, meaning the PTAB’s institution decision is not entirely unreviewable even though institution decisions for IPR proceedings generally are not.
- Enterprise pricing algorithms and hierarchical pricing rule systems are abstract ideas under § 101; computerizing them without adding significantly more does not confer eligibility.
- The decision established the Federal Circuit’s oversight role over the new PTAB CBM program, setting expectations for how the court would apply Alice to challenged business method patents in post-grant review proceedings.
Why It Matters
Versata v. SAP (2015) was the inaugural Federal Circuit decision reviewing a CBM final written decision, making it foundational for the entire CBM program established by the AIA. By confirming that these proceedings receive meaningful appellate review — including on § 101 — the court ensured that PTAB CBM decisions would be subject to the same evolving legal standards as district court § 101 rulings. This gave patent holders a meaningful path to appeal adverse CBM decisions rather than facing unreviewable PTAB rulings.
The decision also reinforced the reach of Alice into enterprise software patents. Versata’s pricing patent covered sophisticated software used in Fortune 500 sales operations, but the Federal Circuit found the core concept — grouping customers and products and applying hierarchical pricing rules — abstract. For companies defending business software patents in CBM or IPR proceedings, the case confirmed that commercial complexity and practical utility do not substitute for the inventive concept required by § 101. The CBM program itself was time-limited under the AIA and expired in September 2020, but decisions like Versata shaped how business method patent validity is assessed in both PTAB proceedings and district courts.